6O6G

Co-crystal structure of Mcl1 with inhibitor

Summary for 6O6G

Entry DOI	10.2210/pdb6o6g/pdb
Descriptor	Induced myeloid leukemia cell differentiation protein Mcl-1, (3S)-5-(cyclobutylmethyl)-3-(2,4-dichlorophenyl)-2,3,4,5-tetrahydro-1,5-benzoxazepine-7-carboxylic acid (3 entities in total)
Functional Keywords	apoptosis, inhibition, apoptosis-inhibitor complex, apoptosis/inhibitor
Biological source	Homo sapiens (Human)
Total number of polymer chains	1
Total formula weight	18199.53
Authors	Huang, X. (deposition date: 2019-03-06, release date: 2019-05-15, Last modification date: 2024-03-13)
Primary citation	Caenepeel, S.,Brown, S.P.,Belmontes, B.,Moody, G.,Keegan, K.S.,Chui, D.,Whittington, D.A.,Huang, X.,Poppe, L.,Cheng, A.C.,Cardozo, M.,Houze, J.,Li, Y.,Lucas, B.,Paras, N.A.,Wang, X.,Taygerly, J.P.,Vimolratana, M.,Zancanella, M.,Zhu, L.,Cajulis, E.,Osgood, T.,Sun, J.,Damon, L.,Egan, R.K.,Greninger, P.,McClanaghan, J.D.,Gong, J.,Moujalled, D.,Pomilio, G.,Beltran, P.,Benes, C.H.,Roberts, A.W.,Huang, D.C.,Wei, A.,Canon, J.,Coxon, A.,Hughes, P.E. AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies. Cancer Discov, 8:1582-1597, 2018 Cited by PubMed: 30254093 DOI: 10.1158/2159-8290.CD-18-0387 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (2.4 Å)

Structure validation